The SMART trial raised questions about balloon-expandable valves in small aortic annuli; these new data offer some answers.

Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid ...

BrioHealth Solutions announced today that it enrolled its first patients in the U.S. for the INNOVATE trial of its BrioVAD ...

Boston Scientific (NYSE:BSX) shared data highlighting the safety and efficacy of its Acurate Prime XL aortic valve system.

An Ukrinform reporter attended a unique heart surgery performed on a newborn just minutes after a cesarean section — ...

A study by a team of Chinese researchers highlights the potential of optical coherence tomography angiography (OCTA) in ...

At a minimum, the study shows that there is a difference in valve hemodynamics between Resilia and Sapien 3/3 Ultra. In ...

The BrioVAD System is a full-support, durable ventricular assist device designed to enhance the quality of life in patients.

Analyst Josh Jennings from TD Cowen maintained a Hold rating on Edwards Lifesciences (EW – Research Report) and keeping the price target at ...

Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim ...

Researchers warn that long-term use of cigarettes or vapes could do lasting damage to blood vessels MONDAY, Nov. 25, 2024 ...